Omepral



Indications and Reactions:

Role Indications Reactions
Primary
Reflux Oesophagitis 18.0%
Hypertension 15.5%
Gastric Ulcer 11.6%
Helicobacter Infection 8.1%
Gastritis 6.6%
Diabetes Mellitus 4.1%
Rheumatoid Arthritis 4.1%
Duodenal Ulcer 3.5%
Insomnia 3.1%
Atrial Fibrillation 2.9%
Gastric Ulcer Helicobacter 2.9%
Schizophrenia 2.7%
Hyperlipidaemia 2.5%
Osteoporosis 2.5%
Constipation 2.3%
Gastrooesophageal Reflux Disease 2.3%
Cardiac Failure Chronic 1.9%
Myocardial Infarction 1.9%
Gastric Ulcer Haemorrhage 1.7%
Gastrointestinal Haemorrhage 1.7%
Interstitial Lung Disease 13.5%
Rhabdomyolysis 13.5%
Hepatic Function Abnormal 7.5%
Colitis Collagenous 6.0%
Liver Disorder 6.0%
White Blood Cell Count Decreased 6.0%
Toxic Epidermal Necrolysis 5.3%
Loss Of Consciousness 4.5%
Blood Creatine Phosphokinase Increased 3.8%
Jaundice 3.8%
Drug Eruption 3.0%
Electrocardiogram Qt Prolonged 3.0%
Gastric Ulcer Haemorrhage 3.0%
Hypokalaemia 3.0%
Oculomucocutaneous Syndrome 3.0%
Pneumonia 3.0%
Road Traffic Accident 3.0%
Stevens-johnson Syndrome 3.0%
Tenderness 3.0%
Thrombocytopenia 3.0%
Secondary
Product Used For Unknown Indication 16.3%
Helicobacter Infection 11.7%
Drug Use For Unknown Indication 10.8%
Hypertension 9.6%
Gastrooesophageal Reflux Disease 8.4%
Gastric Ulcer 6.7%
Rheumatoid Arthritis 6.3%
Prophylaxis 5.0%
Ill-defined Disorder 3.6%
Reflux Oesophagitis 3.1%
Hyperlipidaemia 2.3%
Diabetes Mellitus 2.2%
Duodenal Ulcer 2.2%
Insomnia 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Angina Pectoris 1.8%
Constipation 1.6%
Dyspepsia 1.6%
Gastritis 1.6%
Pneumonia 1.5%
Hepatic Function Abnormal 10.1%
Toxic Epidermal Necrolysis 9.4%
Interstitial Lung Disease 8.8%
White Blood Cell Count Decreased 8.2%
Liver Disorder 6.9%
Stevens-johnson Syndrome 6.3%
Pancytopenia 5.7%
Pyrexia 5.7%
Gamma-glutamyltransferase Increased 5.0%
Subclavian Artery Stenosis 5.0%
Face Oedema 3.8%
Renal Impairment 3.8%
Rhabdomyolysis 3.1%
Sudden Hearing Loss 3.1%
Bone Marrow Failure 2.5%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.5%
Hyperkalaemia 2.5%
Lymphocyte Stimulation Test Positive 2.5%
Urticaria 2.5%
White Blood Cell Count Increased 2.5%
Concomitant
Prophylaxis 15.7%
Hypertension 12.6%
Rheumatoid Arthritis 11.2%
Drug Use For Unknown Indication 10.2%
Product Used For Unknown Indication 8.2%
Constipation 4.2%
Diabetes Mellitus 4.2%
Insomnia 4.0%
Gastritis 4.0%
Gastric Ulcer 3.4%
Cancer Pain 3.3%
Multiple Myeloma 2.5%
Pain 2.4%
Chronic Hepatitis C 2.4%
Osteoporosis 2.2%
Metastatic Renal Cell Carcinoma 2.0%
Reflux Oesophagitis 1.9%
Hepatic Neoplasm Malignant 1.9%
Pneumonia 1.8%
Asthma 1.7%
White Blood Cell Count Decreased 14.3%
Interstitial Lung Disease 7.8%
Renal Impairment 7.0%
Platelet Count Decreased 6.4%
Thrombocytopenia 6.3%
Pyrexia 5.8%
Vomiting 5.6%
Sepsis 5.0%
Pneumonia 4.7%
Respiratory Failure 4.7%
Hepatic Function Abnormal 4.3%
White Blood Cell Count Increased 4.3%
Rash 3.5%
Pneumocystis Jiroveci Pneumonia 3.2%
Liver Disorder 3.1%
Shock 3.1%
Renal Failure Acute 3.0%
Stomatitis 3.0%
Neutrophil Count Decreased 2.6%
Renal Failure 2.6%
Interacting
Hypertension 20.7%
Reflux Oesophagitis 20.7%
Myocardial Infarction 17.2%
Osteoporosis 13.8%
Gastric Ulcer 6.9%
Gastritis 6.9%
Hypercholesterolaemia 6.9%
Hyperlipidaemia 3.4%
Ulcer 3.4%
Platelet Count Decreased 57.1%
Feeling Abnormal 14.3%
Renal Disorder 14.3%
Road Traffic Accident 14.3%